Torrent Pharmaceuticals Limited
NSE: TORNTPHARM BSE: TORNTPHARM
NSE
3,960.80
29.30 (0.78%)
Prev Close
3960.8
Open Price
3980
Volume
39,066
Today Low / High
3926.5 / 4018.3
52 WK Low / High
2886.45 / 4107.2
Range
3,763 - 4,159
BSE
3,959.75
19.25 (0.90%)
Prev Close
3959.75
Open Price
3855.55
Volume
504
Today Low / High
3855.55 / 4009.15
52 WK Low / High
2891.45 / 4124.95
Range
3,762 - 4,158
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 3960.8 (target range: 3,763 - 4,159), reflecting a change of 29.3 (0.7811%). On the BSE, it is listed at 3959.75 (target range: 3,762 - 4,158), showing a change of 19.25 (0.8995%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
01 Feb
3,980.00
-0.60%
30 Jan
3,920.00
1.04%
29 Jan
3,936.00
-0.15%
28 Jan
3,944.60
0.36%
27 Jan
3,968.00
0.74%
23 Jan
4,021.00
-2.21%
22 Jan
3,982.50
0.95%
21 Jan
3,960.00
0.55%
20 Jan
4,105.00
-3.12%
19 Jan
4,033.30
1.32%
16 Jan
4,020.00
-0.04%
14 Jan
3,940.30
1.61%
13 Jan
3,940.00
0.01%
12 Jan
3,960.00
-0.26%
09 Jan
4,016.00
-1.31%
08 Jan
4,080.00
-1.31%
07 Jan
3,936.80
3.95%
06 Jan
3,879.80
1.47%
05 Jan
3,885.30
-0.40%
Torrent Pharmaceuticals Limited Graph
Torrent Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Torrent Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 3,960.80, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 3,959.75 | 3,999.35 | 3,599.41 - 4,399.28 |
| 4,038.95 | 3,231.16 - 4,846.73 | ||
| 4,078.54 | 2,854.98 - 5,302.11 | ||
| Bearish Scenario | 3,959.75 | 3,920.15 | 3,528.14 - 4,312.17 |
| 3,880.56 | 3,104.44 - 4,656.67 | ||
| 3,840.96 | 2,688.67 - 4,993.24 |
Overview of Torrent Pharmaceuticals Limited
ISIN
INE685A01028
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
243,591
Market Cap
1,340,514,698,752
Last Dividend
6
Official Website
IPO Date
2002-07-01
DCF Diff
-7,752.84
DCF
11,683
Financial Ratios Every Investor Needs
Stock Dividend of TORNTPHARM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-06-20 | June 20, 25 | 6 | 6 | 2025-06-20 | 2025-08-04 | |
| 2025-01-31 | January 31, 25 | 26 | 26 | 2025-02-01 | 2025-02-17 | |
| 2024-06-21 | June 21, 24 | 6 | 6 | 2024-06-21 | 2024-08-22 | |
| 2024-02-12 | February 12, 24 | 22 | 22 | 2024-02-12 | 2024-03-03 | |
| 2023-06-23 | June 23, 23 | 8 | 8 | 2023-06-23 | 2023-09-06 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 11,516.09 Cr | 2,775.90 Cr | 8,740.19 Cr | 0.7590 | 581.00 Cr | 738.22 Cr | 5,888.35 Cr | 1,911.00 Cr | 56.47 | 3,675.82 Cr | 0.1659 |
| 2024-03-31 | 10,727.84 Cr | 2,686.21 Cr | 8,041.63 Cr | 0.7496 | 527.00 Cr | 772.28 Cr | 5,497.99 Cr | 1,656.38 Cr | 48.94 | 3,324.90 Cr | 0.1544 |
| 2023-03-31 | 9,620.15 Cr | 2,735.19 Cr | 6,884.96 Cr | 0.7157 | 516.00 Cr | 613.76 Cr | 4,663.78 Cr | 1,245.23 Cr | 36.79 | 2,802.64 Cr | 0.1294 |
| 2022-03-31 | 8,508.04 Cr | 2,442.01 Cr | 6,066.03 Cr | 0.7130 | 516.00 Cr | 554.88 Cr | 4,001.74 Cr | 777.18 Cr | 22.96 | 2,382.31 Cr | 0.0913 |
| 2021-03-31 | 8,004.57 Cr | 2,146.42 Cr | 5,858.15 Cr | 0.7319 | 487.00 Cr | 565.66 Cr | 3,911.46 Cr | 1,251.88 Cr | 36.99 | 2,429.05 Cr | 0.1564 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 579.00 Cr | 14,990.00 Cr | 7,399.00 Cr | 7,591.0000 Cr | 3,202.00 Cr | 2,623.00 Cr | 2,541.00 Cr | 3,822.00 Cr | 0.00 Cr | 0.46 Cr | 57.06 Cr | 4,717.0000 Cr |
| 2024-03-31 | 835.14 Cr | 15,060.58 Cr | 8,204.43 Cr | 6,856.1500 Cr | 4,021.94 Cr | 3,186.80 Cr | 2,279.07 Cr | 3,577.77 Cr | 4.50 Cr | 0.96 Cr | 72.00 Cr | 5,425.2500 Cr |
| 2023-03-31 | 508.00 Cr | 15,012.00 Cr | 8,814.00 Cr | 6,198.0000 Cr | 5,368.00 Cr | 4,860.00 Cr | 2,230.00 Cr | 3,460.00 Cr | 846.00 Cr | 1.46 Cr | 73.61 Cr | 5,447.0000 Cr |
| 2022-03-31 | 398.40 Cr | 13,099.84 Cr | 7,146.89 Cr | 5,952.9500 Cr | 4,069.65 Cr | 3,671.25 Cr | 2,462.32 Cr | 3,246.93 Cr | 732.04 Cr | 1.96 Cr | 94.27 Cr | 4,415.0900 Cr |
| 2021-03-31 | 572.56 Cr | 14,074.65 Cr | 8,237.48 Cr | 5,837.1700 Cr | 4,874.13 Cr | 4,301.57 Cr | 2,681.20 Cr | 3,628.75 Cr | 785.95 Cr | 3.30 Cr | -97.33 Cr | 4,891.6200 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2,585.0000 Cr | -540.0000 Cr | -2,298.0000 Cr | 1,974.0000 Cr | -262.1400 Cr | 573.0000 Cr | -611.0000 Cr | 1,911.0000 Cr | -925.5000 Cr | -1,083.0000 Cr | -262.0000 Cr |
| 2024-03-31 | 3,266.0800 Cr | -167.9000 Cr | -2,779.6400 Cr | 2,833.3000 Cr | 326.6100 Cr | 835.1400 Cr | -432.7800 Cr | 1,656.3800 Cr | -1,369.4400 Cr | -1,015.3400 Cr | -49.0000 Cr |
| 2023-03-31 | 2,368.0000 Cr | -2,415.0000 Cr | 77.0000 Cr | 1,794.0000 Cr | 110.0000 Cr | 508.0000 Cr | -574.0000 Cr | 1,847.0000 Cr | 1,265.1900 Cr | -863.0400 Cr | 256.0000 Cr |
| 2022-03-31 | 1,802.9900 Cr | -196.6300 Cr | -1,781.0500 Cr | 1,600.4200 Cr | -174.1600 Cr | 398.4000 Cr | -202.5700 Cr | 1,225.9100 Cr | -814.3400 Cr | -676.8900 Cr | 218.8800 Cr |
| 2021-03-31 | 2,010.6900 Cr | -449.4200 Cr | -1,656.1300 Cr | 1,675.5400 Cr | -89.2600 Cr | 572.5600 Cr | -335.1500 Cr | 1,526.2600 Cr | -921.8300 Cr | -338.4500 Cr | -532.9800 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 3,246.00 Cr | 800.00 Cr | 2,446.00 Cr | 0.7535 | 879.00 Cr | 591.00 Cr | 17.45 | 1,043.00 Cr | 0.1821 |
| 2025-06-30 | 3,178.00 Cr | 774.00 Cr | 2,404.00 Cr | 0.7565 | 831.00 Cr | 548.00 Cr | 16.19 | 1,018.44 Cr | 0.1724 |
| 2025-03-31 | 2,959.09 Cr | 730.90 Cr | 2,228.19 Cr | 0.7530 | 1,449.35 Cr | 498.00 Cr | 14.71 | 950.50 Cr | 0.1683 |
| 2024-12-31 | 2,809.00 Cr | 673.00 Cr | 2,136.00 Cr | 0.7604 | 1,436.00 Cr | 503.00 Cr | 14.88 | 903.14 Cr | 0.1791 |
| 2024-09-30 | 2,889.00 Cr | 678.00 Cr | 2,211.00 Cr | 0.7653 | 1,523.00 Cr | 453.00 Cr | 13.37 | 938.50 Cr | 0.1568 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 621.00 Cr | 412.00 Cr | 1,033.00 Cr | 2,190.00 Cr | 2,467.00 Cr | 6,171.00 Cr | 3,946.00 Cr | 15,515.00 Cr | 7,066.00 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 687.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -7,590.69 Cr |
| 2025-03-31 | 579.00 Cr | 114.49 Cr | 691.00 Cr | 1,867.00 Cr | 2,541.00 Cr | 5,623.00 Cr | 3,822.00 Cr | 14,990.00 Cr | 7,399.00 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1,235.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -7,504.00 Cr |
| 2024-09-30 | 1,146.00 Cr | 85.00 Cr | 1,235.00 Cr | 1,787.00 Cr | 2,271.00 Cr | 5,879.00 Cr | 3,629.00 Cr | 15,088.00 Cr | 7,584.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 548.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 498.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 503.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 453.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 457.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2022-07-08 | July 08, 22 | 2:1 |
| 2013-07-23 | July 23, 13 | 2:1 |
| 2006-02-20 | February 20, 06 | 2:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,595.30 | ₹3,827,659,077,641.00 | ₹1,676,012.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,032.50 | ₹1,601,439,208,850.00 | ₹65,936.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,960.80 | ₹1,340,514,698,752.00 | ₹39,052.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,223.50 | ₹1,018,647,180,465.00 | ₹305,792.00 |
| Lupin Limited | LUPIN | ₹2,152.80 | ₹983,396,887,200.00 | ₹112,742.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹885.30 | ₹890,818,951,347.00 | ₹113,124.00 |
| Mankind Pharma Limited | MANKIND | ₹2,127.20 | ₹878,118,949,158.00 | ₹277,838.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,191.70 | ₹692,141,294,129.00 | ₹456,701.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,600.00 | ₹669,564,000,000.00 | ₹17,579.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,969.10 | ₹555,681,613,002.00 | ₹275,048.00 |
| Laurus Labs Limited | LAURUSLABS | ₹942.45 | ₹508,787,835,706.00 | ₹1,085,152.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,434.80 | ₹364,014,811,986.00 | ₹36,173.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,787.50 | ₹348,258,051,900.00 | ₹26,755.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,882.70 | ₹302,050,974,500.00 | ₹35,670.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,476.70 | ₹279,941,769,818.00 | ₹42,149.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,382.20 | ₹224,596,675,992.00 | ₹226,955.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,640.00 | ₹216,000,000,000.00 | ₹2,763.00 |
| Eris Lifesciences Limited | ERIS | ₹1,395.50 | ₹190,090,671,391.00 | ₹9,900.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,251.00 | ₹170,008,859,139.00 | ₹49,401.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹784.25 | ₹154,154,629,997.00 | ₹24,000.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹958.65 | ₹151,821,158,920.00 | ₹14,445.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹835.90 | ₹149,717,940,333.00 | ₹193,355.00 |
| Cohance Lifesciences Limited | COHANCE | ₹370.35 | ₹141,683,740,299.00 | ₹135,511.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,809.00 | ₹137,505,158,064.00 | ₹21,919.00 |
| Granules India Limited | GRANULES | ₹559.40 | ₹135,748,879,730.00 | ₹248,397.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹938.60 | ₹115,148,386,600.00 | ₹24,621.00 |
| Viyash Scientific Limited | VIYASH | ₹203.61 | ₹88,815,813,868.00 | ₹225,217.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,303.00 | ₹88,026,522,746.00 | ₹4,599.00 |
| Strides Pharma Science Limited | STAR | ₹877.00 | ₹80,835,470,178.00 | ₹276,195.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹755.20 | ₹68,456,836,429.00 | ₹54,624.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹446.10 | ₹68,298,828,074.00 | ₹44,529.00 |
| FDC Limited | FDC | ₹376.00 | ₹61,216,591,584.00 | ₹29,942.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹288.95 | ₹56,513,365,733.00 | ₹4,259,433.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹126.08 | ₹40,915,681,815.00 | ₹7,502,088.00 |
| Innova Captab Limited | INNOVACAP | ₹699.05 | ₹40,003,086,617.00 | ₹11,783.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹327.55 | ₹35,691,572,551.00 | ₹56,340.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹389.05 | ₹35,508,593,500.00 | ₹57,786.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹694.50 | ₹35,224,418,423.00 | ₹13,893.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,007.90 | ₹33,208,688,219.00 | ₹3,345.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹308.00 | ₹30,887,011,848.00 | ₹23,006.00 |
| Suven Life Sciences Limited | SUVEN | ₹132.81 | ₹30,210,821,940.00 | ₹318,140.00 |
Key Executives
Chief Customer Service Officer
Abdullah Salam Said Al Abri
Gender: male
Year Born:
MD & Whole-Time Director
Aman Mehta
Gender: male
Year Born:
Executive Director of Operations
Ashish Hajarnish
Gender: male
Year Born: 1968
Company Secretary & Compliance Officer
Chintan Trivedi
Gender: male
Year Born:
Vice President of Human Resource
Jaydip Bhatt
Gender: male
Year Born: 1953
President and Chief Executive Officer of Torrent Pharma USA
Sanjay Gupta
Gender: male
Year Born:
Executive Director of Finance & Chief Financial Officer
Sudhir Menon
Gender: male
Year Born: 1972
FAQs about Torrent Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Sanjay Gupta.
What is the current market price of the stock?
The current price is ₹3,960.80.
What is the 52-week price range?
The range is ₹2886.45-4107.2.
What is the market capitalization of the company?
The market capitalization is ₹134,051.47 crores.
What is the dividend yield?
The dividend yield is 0.15%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 62.68.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Torrent Pharmaceuticals Limited (ISIN: INE685A01028) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹134,051.47 crores and an average daily volume of 243,591 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹6.